BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2167339)

  • 1. Azoles and AIDS.
    Larsen RA
    J Infect Dis; 1990 Sep; 162(3):727-30. PubMed ID: 2167339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: treatment of cryptococcal meningitis.
    Sugar AM; Stern JJ; Dupont B
    Rev Infect Dis; 1990; 12 Suppl 3():S338-48. PubMed ID: 2184512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of azoles in antifungal therapy.
    Kauffman CA
    Clin Infect Dis; 1996 May; 22 Suppl 2():S148-53. PubMed ID: 8722843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.
    Vincent-Ballereau FN; Patey ON; Lafaix C
    Pharm Weekbl Sci; 1991 Apr; 13(2):45-57. PubMed ID: 1870943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and therapeutic profile of 3 cases of cryptococcal meningitis in patients with AIDS].
    Michelone G; Tacconi F; Maccabruni A; Lanzarini P; Tinelli M; Dei Cas A
    G Ital Chemioter; 1989; 36(1-3):95-9. PubMed ID: 2562240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-NĂ¼bling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole antifungal agents: emphasis on new triazoles.
    Saag MS; Dismukes WE
    Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antifungal agents for the systemic mycoses.
    Ringel SM
    Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole drug resistance in yeasts.
    Johnson EM; Warnock DW
    J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.
    Goa KL; Barradell LB
    Drugs; 1995 Oct; 50(4):658-90. PubMed ID: 8536553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of microsporidial epithelial keratopathy in a patient with AIDS.
    Yee RW; Tio FO; Martinez JA; Held KS; Shadduck JA; Didier ES
    Ophthalmology; 1991 Feb; 98(2):196-201. PubMed ID: 1848925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
    Supparatpinyo K; Nelson KE; Merz WG; Breslin BJ; Cooper CR; Kamwan C; Sirisanthana T
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2407-11. PubMed ID: 8285625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome.
    de Gans J; Eeftinck Schattenkerk JK; van Ketel RJ
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):339. PubMed ID: 2830934
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of systemic mycoses in patients with AIDS.
    Graybill JR
    Arch Med Res; 1993; 24(4):403-12. PubMed ID: 8118165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.